ROCKet
A clinical trial to test if Ketamine administration during and after surgery will reduce the risk of patients developing long term pain after surgery
Trial ID
ACTRN12617001619336
Cancer Type
Not specific
Status
Open and recruiting
Phase
3 / 4
Brief summary
The aim of this study is to see if giving the drug Ketamine during surgery and for up to three days after reduces development of chronic post-surgical pain in patients having breast, chest or abdominal surgery. Participants are randomly assigned to receive either the drug ketamine or placebo (normal saline) during and after surgery. All participants:
- Complete questionnaires prior to surgery and before discharge from hospital
- Answer follow up questions over the phone three months and one year following surgery
- Have information accessed regarding visits to their GP and any pain medication scripts needed postoperatively (if consenting)
Who can participate
Adult patients who:
- Are having breast, chest or abdominal surgery
- Require a hospital stay of at least one night following surgery
- Do not have a history of stroke, epilepsy or complex regional pain syndrome
For full inclusion / exclusion criteria refer to the Australian Cancer Clinical Trial Registry.